DE2215728C3 - Arzneimittel zur Behandlung von Herpes simplex - Google Patents

Arzneimittel zur Behandlung von Herpes simplex

Info

Publication number
DE2215728C3
DE2215728C3 DE2215728A DE2215728A DE2215728C3 DE 2215728 C3 DE2215728 C3 DE 2215728C3 DE 2215728 A DE2215728 A DE 2215728A DE 2215728 A DE2215728 A DE 2215728A DE 2215728 C3 DE2215728 C3 DE 2215728C3
Authority
DE
Germany
Prior art keywords
virus
herpes simplex
vaccinia
herpes
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2215728A
Other languages
German (de)
English (en)
Other versions
DE2215728A1 (de
DE2215728B2 (de
Inventor
Auf Nichtnennung Antrag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE2215728A priority Critical patent/DE2215728C3/de
Priority to GB1521973A priority patent/GB1379008A/en
Priority to FR7311381A priority patent/FR2182913B1/fr
Publication of DE2215728A1 publication Critical patent/DE2215728A1/de
Publication of DE2215728B2 publication Critical patent/DE2215728B2/de
Application granted granted Critical
Publication of DE2215728C3 publication Critical patent/DE2215728C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2215728A 1972-03-30 1972-03-30 Arzneimittel zur Behandlung von Herpes simplex Expired DE2215728C3 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE2215728A DE2215728C3 (de) 1972-03-30 1972-03-30 Arzneimittel zur Behandlung von Herpes simplex
GB1521973A GB1379008A (en) 1972-03-30 1973-03-29 Medicament for the treatment of herpes simplex
FR7311381A FR2182913B1 (enExample) 1972-03-30 1973-03-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2215728A DE2215728C3 (de) 1972-03-30 1972-03-30 Arzneimittel zur Behandlung von Herpes simplex

Publications (3)

Publication Number Publication Date
DE2215728A1 DE2215728A1 (de) 1973-10-11
DE2215728B2 DE2215728B2 (de) 1978-06-22
DE2215728C3 true DE2215728C3 (de) 1979-02-15

Family

ID=5840732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2215728A Expired DE2215728C3 (de) 1972-03-30 1972-03-30 Arzneimittel zur Behandlung von Herpes simplex

Country Status (3)

Country Link
DE (1) DE2215728C3 (enExample)
FR (1) FR2182913B1 (enExample)
GB (1) GB1379008A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317811A (en) 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390467A (en) * 1973-03-30 1975-04-16 Rit Rech Ind Therapeut Vaccination method using temperature sensitive virus mutants
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
ATE165975T1 (de) * 1993-03-12 1998-05-15 Univ Keele Therapeutische zusammensetzungen die lithiumverbindungen und silika enthalten
FR2825276B1 (fr) * 2001-05-31 2004-11-26 Seppic Sa Adujvant d'immunite sous forme solide et vaccin le contenant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3378443A (en) * 1966-04-05 1968-04-16 American Cyanamid Co Anhydrous liquid suspensions of biologics

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317811A (en) 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine

Also Published As

Publication number Publication date
DE2215728A1 (de) 1973-10-11
FR2182913A1 (enExample) 1973-12-14
DE2215728B2 (de) 1978-06-22
FR2182913B1 (enExample) 1977-04-22
GB1379008A (en) 1975-01-02

Similar Documents

Publication Publication Date Title
DE69414502T2 (de) Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen
DE69434956T2 (de) Auf einer Emusion und MPL basierte Adjuvantien für Impfstoffe
DE3587434T2 (de) Antivirale pharmazeutische Zusammensetzungen und ihrer Verwendung.
DE69205566T2 (de) Herpes-simplex-impfstoff, der hsv-glycoprotein-gd und 3-deacyl monophosphoryl-lipid-a enthaelt.
DE69430440T2 (de) Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
DE69837324T2 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
DE69610295T3 (de) Von einem retroviralen regulationsprotein abstammende, detoxifierte immunogene, dagegen gerichtete antikörper, verfahren zur deren herstellung und diese immunogene oder antikörper enthaltende, pharmazeutische zusammensetzungen.
DE60019726T2 (de) Impfstofformulierung mit monoglyceriden oder fettsäuren als adjuvans
DE2215728C3 (de) Arzneimittel zur Behandlung von Herpes simplex
DE69929616T2 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE69813070T2 (de) Pharmazeutische Zubereitung zur oralen Anwendung enthaltend einen Histamin-Immunoglobulin Komplex
DE60031243T2 (de) Impfstofformulierung gegen tuberkulose mit monoglyceriden oder fettsäuren als adjuvant
DE69328667T2 (de) Flavopereirine enthaltende zusammensetzung und ihre anwendung in der behandlung gegen hiv-viren
DE1617300C3 (de) Dosierungsform für Virus-Zubereitungen
DE69120396T2 (de) Neue verwendung von linomide (r)
EP0331014A2 (de) Verwendung von ACE-Inhibitoren für die Diabetesprophylaxe
EP0885013B1 (de) Verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren zur herstellung von arzneimitteln
DE3344086A1 (de) Verwendung von azaspirogermanium-verbindungen zur behandlung von arthritis
DE3707127C2 (de) Verwendung von Methionin zur Behandlung von Immun-Schwächeerkrankungen bei Virusinfektionen und/oder bei Tumorerkrankungen
DE4329857C2 (de) Verbindung zur Stärkung des Immunsystems und von Immunreaktionen
DE2616406A1 (de) Mittel zur prophylaxe und therapie der gastro-enteritis
DE3720434A1 (de) Verfahren zur erzeugung von spezifischen immunomodulatoren fuer die behandlung von durch viren verursachte immunschwaeche und sie enthaltendes arzneimittel
DE3884811T2 (de) Hyperimmun globulin gegen hiv.
DE19844022C1 (de) Verwendung von eisenbindenden Glycoproteinen und/oder 10-Hydroxy-2-decensäure in Verbindung mit Thymochinon zur Behandlung von AIDS
EP0304897A2 (de) Mittel zur Immunisierung des menschlichen Körpers bei HIV-Infektionen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee